Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Tops & Flops Stocks

Security Change (%) ▲ 1w 1m 1y YTD 3y 5y
Avalo Therapeutics Inc. 2.500% - - - - - -
Eagle Pharmaceuticals Inc 2.560% -8.671% -17.708% -84.040% -29.464% -90.424% -93.299%
Puma Biotechnology Inc. 2.560% -3.800% -22.007% 6.747% -9.245% -59.937% -
MacroGenics Inc. 2.560% -8.706% -72.972% -12.374% -57.356% -84.605% -
Evolus Inc 2.610% 2.609% 0.000% 44.785% 30.387% 26.203% -
Editas Medicine Inc 2.650% -7.679% -8.524% -46.877% -49.076% -83.280% -74.014%
Prothena Corp. plc 2.670% 3.226% -1.538% -70.233% -44.828% -15.044% -
Akero Therapeutics Inc 2.720% 2.813% -11.043% -60.365% -20.367% - -
Cytomx Therapeutics Inc 2.740% -2.905% -62.290% -2.543% 12.536% -71.488% -
Enanta Pharmaceuticals Inc. 2.750% 2.752% -11.811% -52.941% 27.273% -69.730% -86.266%
Esperion Therapeutis.Inc. 2.800% 1.404% 3.168% 56.912% -30.784% -88.593% -95.414%
Karyopharm Therapeutics Inc. 2.810% -9.087% -13.453% -58.035% 6.625% -88.347% -
Geron Corp. 3.000% 1.083% -11.147% -2.680% 66.057% 176.014% 166.993%
Coherus Bioscien. 3.030% -1.416% -13.794% -58.010% -42.747% -83.884% -90.011%
Insmed Inc. 3.060% 138.208% 112.185% 182.123% 76.573% 142.788% 128.714%
Abeona Therapeutics Inc. 3.080% 7.447% 6.316% 31.254% -14.225% -88.100% -
Chromadex Corp 3.150% -8.333% -24.571% 100.000% 97.015% -61.176% -
Sangamo Therapeutics Inc. 3.160% -6.610% 5.980% -52.197% -10.329% -94.199% -93.371%
Vericel Corp. 3.290% -0.901% 0.917% 43.791% 35.802% -1.345% 219.396%
Trevena Inc. 3.500% -4.354% 3.653% -64.420% -44.272% -99.074% -98.698%
Atara Biotherapeutics Inc. 3.940% -9.497% -13.600% -63.812% 2.232% -95.293% -
Assembly Biosciences Inc. 3.990% - - - - - -
Chimerix Inc. 4.710% 3.248% 6.079% -31.354% 6.028% -85.668% -70.164%
Rigel Pharmaceutical Inc. 4.890% 8.019% -9.930% -30.737% -35.025% -69.917% -
Eidos Therapeutics 5.050% - - - - - -